Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has provoked an ongoing global pandemic of coronavirus disease 2019 (COVID-19), which has affected 130 million people worldwide and caused nearly 3 million deaths in just over 1 year [1]. In 2020, COVID-19 represented the third highest cause of death in the USA after heart disease and cancer [2], and this outbreak has led to the largest drop in life expectancy since World War II [2]. Evidence-based medical treatment of COVID-19 (anticoagulants, corticosteroids, anti-inflammatory drugs, oxygenation therapy and ventilation) [3] seems to have improved patients’ outcomes, and the vast majority will recover spontaneously or after acute phase management.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Montani, D., Savale, L., Beurnier, A., Colle, R., Noël, N., Pham, T., Monnet, X., Humbert, M. Tags: Editorials Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Coronavirus | Corticosteroid Therapy | COVID-19 | Heart | Heart Disease | Outbreaks | Pandemics | Respiratory Medicine | SARS